查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1589600

藥物發現外包市場：按工作流程、治療領域、類型和最終用戶分類 - 全球預測 2025-2030

Drug Discovery Outsourcing Market by Workflow, Therapeutics Area, Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年藥物發現外包市場規模為40.1億美元，預計2024年將達到43.8億美元，複合年成長率為9.39%，預計到2030年將達到75.3億美元。

藥物發現外包的調查範圍是將藥物研發過程委託給外部專業機構。藥物發現複雜、成本高且耗時，因此製藥公司需要利用外部專業知識來最佳化資源並加快進度。外包應用於藥物開發的各個階段，從標靶檢驗和先導化合物最佳化到臨床前和臨床試驗管理。最終用途包括製藥公司、生技公司、學術研究機構、CRO（委外研發機構）等。

主要市場統計
基準年[2023] 40.1億美元
預測年份 [2024] 43.8億美元
預測年份 [2030] 75.3億美元
複合年成長率（%） 9.39%

市場洞察表明，製藥公司研發支出的增加、需要廣泛研究的嚴格法律規範以及新治療技術的出現正在推動顯著成長。主要影響因素包括遺傳和生物技術研究的進步、需要創新治療方法的慢性疾病的增加以及研究人才的全球化。量身訂製的外包模式可以在個人化醫療、生技藥品和基因組學領域提供競爭優勢。學術界和工業界之間的合作可以透過縮小創新和商業化之間的差距來進一步推動成長。

然而，挑戰包括知識產權管理、基於地區條件的品管以及應對因地區而異的監管情況。對外包夥伴的可靠性和專業知識的依賴以及時差可能妨礙溝通也會產生限制。

為了利用市場潛力，將人工智慧和機器學習整合到藥物發現中進行預測分析，增強資料管理策略，並投資綠色化學來開發永續的藥物製造方法，您可以將創新重點放在以下方面。此外，與高科技公司建立夥伴關係可以加速數位醫療和遠端醫療解決方案的進步。市場是動態的，監管、創新和競爭不斷交叉。因此，保持成長勢頭並利用新機會需要採取注重協作和技術整合的策略方法。

市場動態：揭示快速發展的藥物發現外包市場的關鍵市場洞察

供需的動態交互作用正在改變藥物發現外包市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 各種慢性病的增加和醫療支出的增加
    • 加大醫藥研發投入
    • 對學名藥和生物創新的需求不斷成長
  • 市場限制因素
    • 外包時的合規問題
  • 市場機會
    • 個人化醫療日益受到關注
    • 增加生技藥品管道並擴大受託製造服務
  • 市場挑戰
    • 嚴格的政府法規

波特五力：駕馭藥物發現外包市場的策略工具

波特的「五力」框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解藥物發現外包市場的外部影響

外部宏觀環境因素在塑造藥物發現外包市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解藥物發現外包市場的競爭狀況

對藥物發現外包市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 藥物發現外包市場中的定位矩陣供應商績效評估

FPNV定位矩陣是評估藥物發現外包市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議 規劃藥物發現外包市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，藥物發現外包市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 各種慢性病盛行率上升和醫療費用上漲
      • 加大醫藥研發投入
      • 對學名藥和生物創新的需求不斷成長
    • 抑制因素
      • 外包時的合規問題
    • 機會
      • 個人化醫療日益受到關注
      • 增加生物製藥管道並擴大契約製造服務
    • 任務
      • 嚴格的政府法規
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章藥物發現外包市場：依工作流程

  • 潛在客戶識別和候選最佳化
  • 臨床前開發
  • 目標識別和篩檢
  • 目標檢驗和功能資訊學

第7章依治療領域分類的藥物發現外包市場

  • 抗感染
  • 心血管
  • 中樞神經系統
  • 皮膚科
  • 內分泌
  • 胃腸道
  • 泌尿生殖系統
  • 血液學
  • 免疫調節
  • 腫瘤學
  • 眼科
  • 疼痛和麻醉
  • 呼吸系統

第8章藥物發現外包市場：按類型

  • 生物服務
  • 化學服務

第9章藥物發現外包市場：依最終用戶分類

  • 學術機構
  • 製藥和生物技術公司

第10章美洲藥物發現外包市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太藥物發現外包市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的藥物發現外包市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Charles River Laboratories
  • Curia Global, Inc.
  • Dalton Pharma Services
  • Eurofins DiscoverX Products
  • Evotec SE
  • GenScript Biotech Corporation
  • Jubilant Biosys Ltd.
  • Laboratory Corporation of America Holdings
  • Merck & Co., Inc.
  • Oncodesign Precision Medicine
  • PPD Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec
Product Code: MRR-742BD517D92E

The Drug Discovery Outsourcing Market was valued at USD 4.01 billion in 2023, expected to reach USD 4.38 billion in 2024, and is projected to grow at a CAGR of 9.39%, to USD 7.53 billion by 2030.

The scope of drug discovery outsourcing encompasses the delegation of research and development processes in pharmaceuticals to specialized external organizations. This practice is necessitated by the complex, costly, and time-consuming nature of drug discovery, compelling pharmaceutical companies to leverage external expertise to optimize resources and accelerate timelines. Outsourcing is applied across various stages of drug development, from target validation and lead optimization to preclinical and clinical trial management. The end-use scope includes pharmaceutical and biotechnology companies, academic and research institutions, and contract research organizations (CROs).

KEY MARKET STATISTICS
Base Year [2023] USD 4.01 billion
Estimated Year [2024] USD 4.38 billion
Forecast Year [2030] USD 7.53 billion
CAGR (%) 9.39%

Market insights reveal significant growth driven by the increasing R&D expenditure by pharmaceutical companies, stringent regulatory frameworks necessitating extensive research, and the advent of novel therapeutic technologies. Key influencing factors include advancements in genetic and biotechnological research, the rising prevalence of chronic diseases demanding innovative therapies, and the globalization of research talent pools. Opportunities abound in personalized medicine, biologics, and genomics, where tailor-made outsourcing models can offer competitive advantages. Collaborations across academia and industry players can further fuel growth by bridging the gap between innovation and commercialization.

However, challenges include managing intellectual property, maintaining quality control across geographical boundaries, and navigating regulatory landscapes that vary by region. Limitations also arise from dependency on the reliability and expertise of outsourcing partners and potential time zone differences hindering communication.

To capitalize on market potential, innovation could focus on integrating artificial intelligence and machine learning for predictive analytics in drug discovery, enhancing data management strategies, and investing in green chemistry to develop sustainable drug production methodologies. Additionally, nurturing partnerships with tech companies can drive advancements in digital health and telemedicine solutions. The market is dynamic, marked by a constant interplay of regulation, innovation, and competition, which necessitates a strategic approach focusing on collaboration and technological integration to maintain growth momentum and capitalize on emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Discovery Outsourcing Market

The Drug Discovery Outsourcing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of various chronic diseases coupled with rising healthcare expenditure
    • Increasing pharmaceutical R&D investment
    • Rising demand for generic drugs and biologic innovation
  • Market Restraints
    • Compliance issues while outsourcing
  • Market Opportunities
    • Increased focus on personalized medicine
    • Growing number of biologics pipeline and growing contract manufacturing service
  • Market Challenges
    • Stringent government regulations

Porter's Five Forces: A Strategic Tool for Navigating the Drug Discovery Outsourcing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Discovery Outsourcing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Discovery Outsourcing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Discovery Outsourcing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Discovery Outsourcing Market

A detailed market share analysis in the Drug Discovery Outsourcing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Discovery Outsourcing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Discovery Outsourcing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Discovery Outsourcing Market

A strategic analysis of the Drug Discovery Outsourcing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Charles River Laboratories, Curia Global, Inc., Dalton Pharma Services, Eurofins DiscoverX Products, Evotec SE, GenScript Biotech Corporation, Jubilant Biosys Ltd., Laboratory Corporation of America Holdings, Merck & Co., Inc., Oncodesign Precision Medicine, PPD Inc., Thermo Fisher Scientific Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Workflow, market is studied across Lead Identification & Candidate Optimization, Preclinical Development, Target Identification & Screening, and Target Validation & Functional Informatics.
  • Based on Therapeutics Area, market is studied across Anti-Infective, Cardiovascular, Central Nervous System, Dermatology, Endocrine, Gastrointestinal, Genitourinary System, Hematology, Immunomodulation, Oncology, Ophthalmology, Pain & Anesthesia, and Respiratory System.
  • Based on Type, market is studied across Biology Services and Chemistry Services.
  • Based on End-User, market is studied across Academic Institutes and Pharmaceutical & Biotechnology companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of various chronic diseases coupled with rising healthcare expenditure
      • 5.1.1.2. Increasing pharmaceutical R&D investment
      • 5.1.1.3. Rising demand for generic drugs and biologic innovation
    • 5.1.2. Restraints
      • 5.1.2.1. Compliance issues while outsourcing
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased focus on personalized medicine
      • 5.1.3.2. Growing number of biologics pipeline and growing contract manufacturing service
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Discovery Outsourcing Market, by Workflow

  • 6.1. Introduction
  • 6.2. Lead Identification & Candidate Optimization
  • 6.3. Preclinical Development
  • 6.4. Target Identification & Screening
  • 6.5. Target Validation & Functional Informatics

7. Drug Discovery Outsourcing Market, by Therapeutics Area

  • 7.1. Introduction
  • 7.2. Anti-Infective
  • 7.3. Cardiovascular
  • 7.4. Central Nervous System
  • 7.5. Dermatology
  • 7.6. Endocrine
  • 7.7. Gastrointestinal
  • 7.8. Genitourinary System
  • 7.9. Hematology
  • 7.10. Immunomodulation
  • 7.11. Oncology
  • 7.12. Ophthalmology
  • 7.13. Pain & Anesthesia
  • 7.14. Respiratory System

8. Drug Discovery Outsourcing Market, by Type

  • 8.1. Introduction
  • 8.2. Biology Services
  • 8.3. Chemistry Services

9. Drug Discovery Outsourcing Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Institutes
  • 9.3. Pharmaceutical & Biotechnology companies

10. Americas Drug Discovery Outsourcing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Drug Discovery Outsourcing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Drug Discovery Outsourcing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Charles River Laboratories
  • 2. Curia Global, Inc.
  • 3. Dalton Pharma Services
  • 4. Eurofins DiscoverX Products
  • 5. Evotec SE
  • 6. GenScript Biotech Corporation
  • 7. Jubilant Biosys Ltd.
  • 8. Laboratory Corporation of America Holdings
  • 9. Merck & Co., Inc.
  • 10. Oncodesign Precision Medicine
  • 11. PPD Inc.
  • 12. Thermo Fisher Scientific Inc.
  • 13. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. DRUG DISCOVERY OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DRUG DISCOVERY OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DRUG DISCOVERY OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DISCOVERY OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DISCOVERY OUTSOURCING MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY LEAD IDENTIFICATION & CANDIDATE OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET IDENTIFICATION & SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TARGET VALIDATION & FUNCTIONAL INFORMATICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ANTI-INFECTIVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ENDOCRINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY GENITOURINARY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY IMMUNOMODULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PAIN & ANESTHESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY RESPIRATORY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY BIOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY CHEMISTRY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 80. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 84. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 88. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 92. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 96. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 100. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 104. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 108. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 117. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 121. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 125. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 129. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 133. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 137. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 141. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 145. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 149. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 153. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 157. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 161. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 165. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 169. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 173. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 177. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 181. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 185. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 189. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY THERAPEUTICS AREA, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM DRUG DISCOVERY OUTSOURCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. DRUG DISCOVERY OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 201. DRUG DISCOVERY OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023